Tatsis Ourania 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Mar 12, 2025
Insider Transaction Report
Form 4
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Transactions
- Sale
Common Stock
2025-03-10$499.99/sh−3,242$1,620,968→ 51,239 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024.